Today’s AI Top Pick: PSIX

10/1/2026 · Highly Shorted Deep Rotation RSI & Conf screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PSIX82%463 resolved forecasts · 45d window · verify →

View the live PSIX price forecast →

Today's pick · Highly Shorted Deep Rotation RSI & ConfPSIXBUY NOW14.3 / 1010/1/2026

PSIX is the only name in the pool that achieves clean multi-timeframe agreement while sitting at a low position in its range. On the 4h it is at 46.08 with fc_short_pct of 80.14 and fc_long_pct of 75.12 (both strongly positive), sitting 89.1% of the way through its 21-bar range but only -2.99% off the high — the forecast cone is pointing up across all three horizons. The 1d shows fc_long_pct of 32.93 with pos_in_21bar_range_pct of 91.06 and just -2.17% drawdown, and the 1wk fc_long_pct of -44.65 reflects a longer-cycle base rather than a breakdown. Bullish probability is 1.0 and near_term_bullish is 1.0, meaning the model sees both immediate and sustained upside. Fundamentally it is the strongest candidate in the pool: P/E 15.63, forward P/E just 11.78, ROE 40.07%, sales YoY +13.17%, operating margin 13%, and a 51.8% analyst target upside, with a recommendation of 1 (strong buy). Short float of 21% provides the squeeze fuel the screen is built around. Critically, the news flow is a clean tailwind: on 2026-09-30 the company secured a $220M committed revolving credit facility — no dilution, no guidance cut, no short-seller report, just balance-sheet capacity to fund growth. This is the ideal convergence: strong fundamentals, positive forecast tape, low drawdown, and a catalyst that reinforces rather than undercuts the thesis. Today is the right entry because the 4h/1d forecast cones are elevated but not extended, the credit facility removes funding risk, and waiting risks a short-squeeze move given 21% short interest against a 40% ROE business trading at a forward P/E under 12. The entry is justified by the fact that PSIX is not chasing — despite being 89% through its 21-bar range intraday, the drawdown is minimal (-2.99% on 4h) and the multi-timeframe forecast is uniformly positive, so the pullback-to-buy logic is satisfied by the forecast cone rather than waiting for a lower price that may not come given the bullish probability of 1.0.

PSIX forecast chart
Entry zone
Buy at or near current levels (~$46.00-46.50 on 4h/1d); add on any dip toward $45.00 which aligns with the 21-bar support zone
Stop loss
Close below $43.50 (below the 21-bar low and beyond the -2.99% drawdown tolerance)
First target
$51.50 (near-term retest of the 21-bar high with squeeze extension)
Longer target
$58-60 (aligned with the 51.8% analyst target upside and forward P/E re-rating to 12-13x
Risks
  • Short float of 21% cuts both ways — a failed squeeze could accelerate downside on low volume
  • perfYear of -53.2% shows a broken longer-term trend that could reassert if macro weakens
  • perfYtd of -19.55% indicates the stock is still in a downtrend and could gap lower on market stress
  • peg of 2.01 suggests the forward earnings growth is already priced in, limiting multiple expansion
  • instOwn of only 35.07% means lower institutional coverage and higher volatility risk
Honorable mentions
SMMTSecond pick due to the $2B AstraZeneca investment on 2026-09-29 (stock jumped 17%) as a massive positive catalyst, bullish_prob 0.8, and short float of 26.97%. However, it lacks fundamentals coverage (no P/E, no margins) and the multi-timeframe forecast is mixed (fc_long_pct negative across 4h/1d/1wk), so it is a narrative trade rather than a technical-confluence trade.
SERVThird pick because near_term_bullish is 1.0 and bullish_prob is 1.0 with a 31% short interest that Barchart flagged as a potential squeeze setup. The 1d fc_long_pct of 97.98 is the strongest in the pool. But it has no fundamentals (negative margins, P/S of 51.76) and the 1wk fc_long_pct of -43.94 shows a weak longer-term trend, making it a higher-risk speculative play.
GRRRFourth pick on strong positive catalysts (StoneX Buy rating, $25 target, multi-year Taiwan AI contract) and short float of 19.42%. However, near_term_bullish is 0 and the 4h fc_long_pct of 75.12 is offset by a -33.27% drawdown and fc_long_pct of 14.85 on 4h, so the technical confluence is weaker than PSIX despite the compelling AI narrative.
Full ranking (29)
#SymbolVerdictScoreRead
1PSIXBUY NOW14.3Clean multi-timeframe bullish agreement, 40% ROE, forward P/E under 12, 21% short float, and a $220M credit facility catalyst — the ideal convergence.
2GRRRBUY PULLBACK8.8Strong AI catalysts and 19% short float but near_term_bullish is 0 and the 4h drawdown of -33% warns against chasing.
3SMMTBUY PULLBACK8.3$2B AstraZeneca investment is a huge catalyst but no fundamentals and mixed multi-timeframe forecast limit conviction.
4CRMLBUY PULLBACK8.331% short float and critical minerals narrative but no fundamentals and a -27.67% 4h drawdown with fc_long_pct of 45.02.
5SERVBUY PULLBACK8.0near_term_bullish of 1.0 and 31% short float are compelling but negative margins and a -43.94% 1wk forecast cap the setup.
6BLSHWAIT8.0Bullish but KBW cut its target to $40 and near_term_bullish is null, so wait for a clearer technical read.
7XPOFBUY PULLBACK7.830% short float and 78% gross margin are attractive but guidance cuts and a UBS target cut to $4.5 are a landmine.
8BTBTBUY PULLBACK7.5near_term_bullish of 0.8 and 18% short float but crypto exposure and negative margins add volatility risk.
9TGTXWAIT7.5Strong BRIUMVI growth and 21% short float but expected_return is -40% and near_term_bullish is 0, so wait.
10EBSBUY PULLBACK7.0near_term_bullish of 0.8 and a Buy rating but the Naloxone breakdown headline is a partial landmine.
11SEIWAIT6.5Positive earnings and 27% short float but near_term_bullish is 0 and the $1B notes issue adds leverage risk.
12PRGOWAIT6.3Defensive pharma with 16% short float but negative margins and a -14.78% fc_long_pct on 1d limit the setup.
13GEMIWAIT6.0Gemini crypto exposure and 27% short float but near_term_bullish is null and the setup is unclear.
14ARQTBUY PULLBACK5.816% short float and Simone Biles catalyst are nice but a 127x P/E and near_term_bullish of 0.4 warrant caution.
15ARQQWAIT5.641% short float is the highest in the pool but P/S of 384 and near_term_bullish of 0.2 make it a speculative hold.
16TDCBUY PULLBACK5.5Cheap at 6x P/E with 17% short float but a COO dumping $1.4M and near_term_bullish of 0.4 are red flags.
17AMKRWAIT5.5Semiconductor tailwind and 16% short float but near_term_bullish is 0 and the 4h drawdown of -34.6% warns off chasers.
18UPXIWAIT5.4Overweight from Cantor at $2 target but near_term_bullish is 0 and negative margins limit conviction.
19OMERWAIT5.3Overweight upgrade and transplant drug upside but a CAO sell and near_term_bullish of 0 make it a wait.
20BIRDBUY PULLBACK5.3$450M funding and 206% target upside are compelling but near_term_bullish of 0.2 and -32% 1wk forecast cap the setup.
21CDZIBUY PULLBACK5.117% short float and dividend support but debt/equity of 25.69 and negative margins are serious cautions.
22GOWAIT5.0B of A upgrade to Buy is positive but negative margins and near_term_bullish of 0 limit the setup.
23RXRXWAIT5.037% short float and AI-drug narrative are attractive but near_term_bullish of 0.4 and negative margins warrant a wait.
24SIGWAIT4.8Value at 11x P/E with 16% short float but near_term_bullish of 0 and a -3.24% 4h drawdown suggest patience.
25STAABUY PULLBACK4.7Stifel upgrade and China growth catalyst with 15% short float but a 340x P/E is stretched.
26CEPTWAIT4.548% short float is the highest but near_term_bullish is null and the data is stale (as of Jul 18).
27INOBUY PULLBACK9.5PDUFA date on Oct 30 is a binary catalyst with 19% short float but near_term_bullish of 0.6 and -100% sales YoY add risk.
28KULRBUY PULLBACK9.815% short float and cash runway but a SeekingAlpha cash burn headline and near_term_bullish of 0.2 limit conviction.
29TSSIBUY PULLBACK11.8Margin improvement narrative and 18% short float but sales YoY of -26.52% and near_term_bullish of 0.4 cap the setup.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.